|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tian R, Zhang C, Xiong F and Chen H:
PCAT1/miR-129/ABCB1 axis confers chemoresistance in non-small cell
lung cancer. Front Biosci (Landmark Ed). 25:948–960. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Y, He LR, Gao Y, Zhou NN, Liu Y, Zhou
XK, Liu JF, Guan XY, Ma NF and Xie D: CHD1L contributes to
cisplatin resistance by upregulating the ABCB1-NF-κB axis in human
non-small-cell lung cancer. Cell Death Dis. 10:992019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vasiliou V, Vasiliou K and Nebert DW:
Human ATP-binding cassette (ABC) transporter family. Hum Genomics.
3:281–290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pérez-Tomás R: Multidrug resistance:
Retrospect and prospects in anti-cancer drug treatment. Curr Med
Chem. 13:1859–1876. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Z, Shi T, Zhang L, Zhu P, Deng M,
Huang C, Hu T, Jiang L and Li J: Mammalian drug efflux transporters
of the ATP binding cassette (ABC) family in multidrug resistance: A
review of the past decade. Cancer Lett. 370:153–164. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Manna S: An overview of pentatricopeptide
repeat proteins and their applications. Biochimie. 113:93–99. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cui J, Wang L, Ren X, Zhang Y and Zhang H:
LRPPRC: A multifunctional protein involved in energy metabolism and
human disease. Front Physiol. 10:5952019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tian T, Ikeda J, Wang Y, Mamat S, Luo W,
Aozasa K and Morii E: Role of leucine-rich pentatricopeptide repeat
motif-containing protein (lrpprc) for anti-apoptosis and
tumourigenesis in cancers. Eur J Cancer. 48:2462–2473. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang HY, Ma YD, Zhang Y, Cui J and Wang
ZM: Elevated Levels of autophagy-related marker ULK1 and
mitochondrion-associated autophagy inhibitor LRPPRC are associated
with biochemical progression and overall survival after androgen
deprivation therapy in patients with metastatic prostate cancer. J
Clin Pathol. 70:383–389. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Corrêa S, Binato R, Du Rocher B, Ferreira
G, Cappelletti P, Soares-Lima S, Pinto LF, Mencalha A and Abdelhay
E: ABCB1 regulation through LRPPRC is influenced by the methylation
status of the GC −100 box in its promoter. Epigenetics.
9:1172–1183. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Labialle S, Dayan G, Gayet L, Rigal D,
Gambrelle J and Baggetto LG: New invMED1 element cis-activates
human multidrug-related ABCB1 and MVP genes, involving the LRP130
protein. Nucleic Acids Res. 32:3864–3876. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fahrmann JF, Grapov D, Phinney BS, Stroble
C, DeFelice BC, Rom W, Gandara DR, Zhang Y, Fiehn O, Pass H and
Miyamoto S: Proteomic profiling of lung adenocarcinoma indicates
heightened DNA repair, antioxidant mechanisms and identifies LASP1
as a potential negative predictor of survival. Clin Proteomics.
13:312016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Corrêa S, Pizzatti L, Du Rocher B,
Mencalha A, Pinto D and Abdelhay E: A comparative proteomic study
identified LRPPRC and MCM7 as putative actors in imatinib mesylate
cross-resistance in lucena cell line. Proteome Sci. 10:232012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Corrêa S, Pizzatti L, Du Rocher B and
Abdelhay E: Comparative proteomic study of multidrug resistance in
chronic myeloid leukemia. Eur J Cancer Supplements. 8:2042010.
View Article : Google Scholar
|
|
17
|
Li X, Lv L, Zheng J, Zhou J, Liu B, Chen
H, Liang C, Wang R, Su L, Li X and Fan D: The significance of
LRPPRC overexpression in gastric cancer. Med Oncol. 31:8182014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li X, Zhou J and Li X: Reversal of
multidrug resistance in gastric cancer cells by LRPPRC
downregulation. J Digest Dis. 15:842014.
|
|
19
|
Michaud M, Barakat S, Magnard S, Rigal D
and Baggetto LG: Leucine-rich protein 130 contributes to apoptosis
resistance of human hepatocarcinoma cells. Int J Oncol. 38:169–178.
2011.PubMed/NCBI
|
|
20
|
Choi HS, Kim YK and Yun PY: Upregulation
of MDR- and EMT-related molecules in cisplatin-resistant human oral
squamous cell carcinoma cell lines. Int J Mol Sci. 20:E30342019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Januchowski R, Sterzyńska K, Zaorska K,
Sosińska P, Klejewski A, Brązert M, Nowicki M and Zabel M: Analysis
of MDR genes expression and cross-resistance in eight drug
resistant ovarian cancer cell lines. J Ovarian Res. 9:652016.
View Article : Google Scholar : PubMed/NCBI
|
